Curaleaf products now available to adults 21 and over at approved dispensaries across Connecticut
NEW YORK, January 10, 2023 – Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced that it has received its hybrid producer license from Connecticut’s Department of Consumer Protection to supply cannabis to the state’s adult-use market, which launches today.
Beginning at 10:00 a.m. ET on Tuesday, January 10, consumers over the age of 21 can purchase Curaleaf products in dispensaries approved for adult use sales across the state. The locations are Affinity Health & Wellness in New Haven, Rise in Branford, The Botanist in Montville, Fine Fettle in Newington, Stamford and Willimantic, and Willow Brook Wellness by Zen Leaf in Meriden. Products will vary by dispensary and include Curaleaf whole flower, pre-rolls, Select Elite vapes, and Curaleaf’s breakthrough vape hardware, Cliq by Select. Curaleaf team members will participate in onsite event activations and celebrations at each of the approved adult-use dispensaries on Tuesday, January 10.
Curaleaf serves patients at its four Connecticut dispensaries in Stamford, Hartford, Milford and Groton, and anticipates welcoming adult-use customers in the near future, pending regulatory approvals. Curaleaf will continue to prioritize patient care for individuals registered in the state’s medical marijuana program during this period of expansion.
“We are proud to provide Curaleaf products across the state as Connecticut celebrates this important milestone in opening a safe and equitable adult-use cannabis market,” said Matt Darin, CEO of Curaleaf. “We commend Governor Lamont and the state legislature for their leadership in the recent expungement of low-level cannabis convictions for over 40,000 residents as part the state’s legalization measure.”
Connecticut is now one of 21 states to legalize adult-use cannabis sales in the U.S. The state is expected to generate over $215 million in revenue in the first year of adult-use sales. For more information on Curaleaf’s locations, patient resources and products in Connecticut, please visit https://ct.curaleaf.com/.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 21 states with 145 dispensaries, 29 cultivation sites, and employs nearly 6,000 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.